(Q42081184)

English

The effect of rizatriptan, ergotamine, and their combination on human peripheral arteries: a double-blind, placebo-controlled, crossover study in normal subjects

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

The effect of rizatriptan, ergotamine, and their combination on human peripheral arteries: a double-blind, placebo-controlled, crossover study in normal subjects (English)

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

0 references

Peer Carsten Tfelt-Hansen

1

object named as

Peer Tfelt-Hansen

1 reference

Europe PubMed Central

16 October 2017

PMC publication ID

author name string

Kaj Seidelin

2

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Michael Stepanavage

3

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Christopher Lines

4

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

language of work or name

0 references

publication date

1 July 2002

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

54

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

1

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

38-44

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874381

30 May 2018

Ergotamine in the acute treatment of migraine: a review and European consensus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874381

30 May 2018

Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874381

30 May 2018

Cardiovascular safety of 5HT1B/1D agonists--is there a cause for concern?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874381

30 May 2018

Coronary side-effect potential of current and prospective antimigraine drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874381

30 May 2018

The autonomic nervous system and the regulation of arterial tone in migraine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874381

30 May 2018

Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874381

30 May 2018

Myocardial ischemia related to ergot alkaloids: a case report and literature review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874381

30 May 2018

Mode of action of the anti-migraine drug sumatriptan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874381

30 May 2018

Vascular effects of 5-HT1B/1D-receptor agonists in patients with migraine headaches.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874381

17 August 2018

Effects of dihydroergotamine and sumatriptan on isolated human cerebral and peripheral arteries and veins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874381

17 August 2018

5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874381

17 August 2018

5-Hydroxytryptamine receptor characterizations of human cerebral, middle meningeal and temporal arteries: regional differences

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2002.01403.X

21 January 2018

The effect of single dose ergotamine tartrate on peripheral arteries in migraine patients: methodological aspects and time effect curve

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874381

3 November 2018

Arterial response to ergotamine tartrate in abusing and non-abusing migraine patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874381

3 November 2018

Dose-response curve for the ergotamine-induced decrease of peripheral systolic blood pressure in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/12100223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intramuscular ergotamine: plasma levels and dynamic activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/12100223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of ergotamine on the arterial system in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/12100223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of pharmacodynamic effects and plasma levels of oral and rectal ergotamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/12100223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-HT receptors mediating contractions of the isolated human coronary artery

1 reference

https://pubmed.ncbi.nlm.nih.gov/12100223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral vascular effects and pharmacokinetics of the antimigraine compound, zolmitriptan, in combination with oral ergotamine in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/12100223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1046/J.1365-2125.2002.01403.X

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42081184&oldid=1933464627"